A original investigational completely automatic “man made pancreas” system that combines posthaste-acting insulin aspart (Fiasp, Novo Nordisk) and pramlintide (Symlin, AstraZeneca) performed equally to a…
A original investigational completely automatic “man made pancreas” system that combines posthaste-acting insulin aspart (Fiasp, Novo Nordisk) and pramlintide (Symlin, AstraZeneca) performed equally to a…